Design Beyond Crisis

RISD Center for Complexity, Spring 2022

Research & Development, Strategy


What comes after a crisis?



Click images to enlarge!

On July 8th, 2021, Rhode Island authorized a 2-year pilot program to open the nation’s first harm reduction centers, also known as overdose prevention or supervised injection sites.

As a member of the CfC Design Beyond Crisis studio, I explored the far-reaching implications of this legislation on local care systems and community members. I performed research on the current state of harm reduction, spoke with diverse stakeholders, and developed a framework to help organizations navigate the future of harm reduction.

I later used this framework to design several interventions for overdose prevention: Beacon, Safe and Sound, and Push.

Role: Researcher, Designer

In Conversation With:
   - RISD Center for Complexity
   - Project WEBER*RENEW
   - COBRE On Opioids and Overdoses

Outcome: To discover opportunities for designed interventions within the current harm reduction landscape.

Research Process


Research and Design Principles 


How do we engage in ethical research activities with historically underserved populations? 


As a studio, we outlined the ethical principles by which our design and research would operate for the rest of the project.




Stakeholder Interviews


What are some different perspectives on harm reduction in our community?


How has the overdose crisis impacted people’s lives? 


What are the biggest obstacles to advancing successful harm reduction programs/policies?


We had the opportunity to speak with some key stakeholders, including community health workers, harm reduction advocates, and people with lived experience of substance use.






Site Visit + Usability Testing


What’s the user journey of someone trying to access harm reduction services?


Is safer drug use accessible?


I visited Project WEBER*Renew at their Kennedy Plaza location, where they provide harm reduction supplies, water, and other basic needs for free.

I waited in line to request test strips and observed others as they interacted with the stand. 

After leaving the stand, I tested the strips for their usability; I observed others using the test strips and attempted to use one myself.  I learned that, while gaining access to the strips was easy, actually using them posed several challenges.


Key Findings


Harm reduction services and organizations are accessible, but stigma prevents people from engaging with these interventions at larger scale. 







Our culture doesn’t view safer drug use as an urgent public health issue. This leads to health interventions and care for people who use drugs to be de-prioritized and stigmatized.


Framework & Interventions


With newly acquired knowledge and insights from our research, I constructed a strategy for the future of harm reduction. I created a timeline of 3 goals, based off of the 3 Horizons Framework.


Our most long-term, overarching goal in harm reduction should be to protect the right of people who use drugs to a safe supply. We must believe that people do not deserve death, disease, or injury due to the substances they use. This is most readily accomplished through governmental regulations, such as those in Colorado regulating marijuana potency.

Before we can regulate drug supply, we must have know what’s in the drugs in the first place. Our medium-term goal, therefore, must be to make a drug checking service available in Rhode Island. In countries like Australia, Austria and Canada, drug checking services inform users about what’s present in their drugs, and empower them to make more informed choices about their drug use.

It may take several years to establish a drug checking service in RI, but the overdose crisis will not wait for us. Our most urgent and immediate goal should be to increase engagement and accessibility of fentanyl testing.



Based off these goals, and off the gaps in current harm reduction practices, I designed 3 different interventions: Beacon, Safe and Sound, and Push. In each of these interventions, I considered how the design and implementation could contribute to destigmatizing the topic of safer drug use and harm reduction.